Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration

ncbi.nlm.nih.gov/pubmed

A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol

academic.oup.com

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

ncbi.nlm.nih.gov/pubmed

The effects of systemic immunomodulatory treatments on COVID‐19 outcomes in patients with atopic dermatitis: Results from the global SECURE‐AD registry.

ncbi.nlm.nih.gov/pubmed

Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.

ncbi.nlm.nih.gov/pubmed

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

ncbi.nlm.nih.gov/pubmed

The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczema.

ncbi.nlm.nih.gov/pubmed

TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.

ncbi.nlm.nih.gov/pubmed

TREatment of ATopic eczema (TREAT) Registry Taskforce: An international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.

ncbi.nlm.nih.gov/pubmed

The international TREatment of ATopic eczema (TREAT) Registry Taskforce: an initiative to harmonise data collection across national atopic eczema photo- and systemic therapy registries.

ncbi.nlm.nih.gov/pubmed